DEP-Trastuzumab

Dendrimer-Trastuzumab

Starpharma Holdings Limited

Drug Names(s): Dendrimer-Trastuzumab, DEP-Trastuzumab
Description: Dendrimer-Trastuzumab is a proprietary formulation wherein trastuzumab is formulated with the dendrimer delivery platform.

Dendrimers (1-100nm) are constructed by the successive addition of layers of branching groups. Each new layer is called a generation. The final generation incorporates the surface molecules that give the dendrimer the desired function for pharmaceutical, life science, chemical, electronic and materials applications.